Σάββατο 5 Ιανουαρίου 2019

Autologous Intestinal Reconstructive Surgery in the Management of Total Intestinal Aganglionosis

Objectives: Total/Near Total intestinal aganglionosis (TIA/NTIA) is the most uncommon and life-threatening form of Hirschsprung disease (HD). The management of TIA/NTIA is challenging and the role of autologous intestinal reconstructive (AIR) surgery is controversial. The objective is to evaluate the effectiveness of AIR in patients with TIA/NTIA. Methods: Records from children affected by total intestinal aganglionosis and enrolled in the multicenter international Pediatric Intestinal Rehabilitation and Transplantation Registry (PIRAT) were retrospectively reviewed. Results: Fourteen patients with TIA were identified. TIA diagnosis was confirmed histologically at the median age of 14 days of life. All received a proximal decompressive jejunostomy. Two patients died, four patients had satisfactory stoma output with enteral tolerance without additional procedures, eight underwent ten AIR procedures (4 Ziegler myotomy-myectomy, 3 transposition of aganglionic ileum with or without myotomy, 2 simple tapering, 1 longitudinal lengthening and tailoring procedure with associated myotomy). AIR significantly reduced median stoma output, from 197 to 31 ml/kg/day (p = 0.0001). The reduction was seen in all patients. In addition, AIR improved enteral tolerance in the long-term in five of eight patients (63%), and temporarily in one, leading to a reduction of PN requirement from 100% to 70% (p = 0.0231). Conclusion: AIR surgery in carefully selected patients may be useful and effective way to enhance residual bowel absorptive function and to reduce PN requirements. AIR and Intestinal transplantation (ITx) are complementary surgical tools in the complex treatment algorithm of TIA/NTIA. Address correspondence and reprint requests to Fabio Fusaro, Department of Medical and Surgical Neonatology, Newborn Surgery Unit, Bambino Gesù Children's Hospital Research Institute, Piazza S. Onofrio 4, 00165 Rome - Italy (. e-mail: fabio.fusaro@opbg.net). Received 28 October, 2018 Revised 23 December, 2018 Accepted 25 December, 2018 Conflicts of interest and source of funding: The Authors declare that there is no conflict of interest or funding source to declare regarding the publication of this article. © 2019 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,

from Gastroenterology via xlomafota13 on Inoreader http://bit.ly/2RfME6b
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.